Multiple myeloma trials in Germany

In Germany 64 Also abroad 704

64 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.

Phase 1/2RecruitingTrial-stage medicine
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma
Where
Berlin, Chemnitz, Greifswald, Hamburg, Heidelberg, Luebeck, Ulm
Age
18 years and over
People
45
Run by
Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT05853965EU 2024-511794-30-00Registry updated 2026-05-18
No phaseRecruitingResearch participation
BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma
Where
Hamburg
Age
18 years and over
People
45
Run by
Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07564219Registry updated 2026-05-04
Phase 3RecruitingTrial-stage medicine
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Where
Chemnitz, Cologne, Dresden, Hamburg, Hanover, Jena, Luebeck, Mainz, Wuerzburg
Age
18 years and over
People
520 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06679101EU 2024-516030-35-00Registry updated 2026-04-22
Phase 3RecruitingTrial-stage medicine
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Where
Greifswald, Luebeck, Wuerzburg
Age
18 years and over
People
1,000 worldwide
Run by
European Myeloma Network B.V.
See details and how to joinNCT06932562EU 2024-519827-16-00Registry updated 2026-03-25
Phase 1RecruitingTrial-stage medicine
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Where
Cologne, Heidelberg, Wuerzburg
Age
18 years and over
People
187 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06153251EU 2023-506003-26-00Registry updated 2026-03-18
No phaseRecruitingResearch participation
Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
Where
Berlin
Age
18 years and over
People
75 worldwide
Run by
Takeda
See details and how to joinNCT05879757Registry updated 2026-02-18
No phaseNot yet recruitingResearch participation
Exercise Therapy for Multiple Myeloma Patients
Where
Heidelberg
Age
18 years to 75 years
People
71
Run by
University Hospital Heidelberg
See details and how to joinNCT07388147Registry updated 2026-02-04
No phaseRecruitingResearch participation
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Where
Essen
People
50 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06357754Registry updated 2026-01-22
No phaseRecruitingResearch participation
Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients
Where
Heidelberg
Age
18 years and over
People
60
Run by
University Hospital Heidelberg
See details and how to joinNCT07044427Registry updated 2026-01-22
Phase 2RecruitingTrial-stage medicine
GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5
Where
Berlin, Chemnitz, Dresden, Duesseldorf, Freiburg im Breisgau, Hamburg, Heidelberg, Kiel, Munich, Wuerzburg
Age
18 years to 70 years
People
160
Run by
University of Heidelberg Medical Center
See details and how to joinNCT05695508EU 2024-517382-17-00Registry updated 2025-12-24
No phaseRecruitingResearch participation
GMMG Multiple Myeloma Registry
Where
Berlin, Bielefeld, Bochum, Bonn, Chemnitz, Cologne, Darmstadt, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Giessen, Hagen, Hamburg, Heidelberg, Heilbronn, Homburg, Kaiserslautern, Koblenz, Lebach, Mainz, Mannheim, Marburg, Mönchengladbach, Regensburg, Schwäbisch Hall, Siegburg, Speyer, Trier, Tübingen
Age
18 years and over
People
999
Run by
Prof. Dr. Hartmut Goldschmidt
See details and how to joinNCT07111884Registry updated 2025-08-08
Phase 3RecruitingResearch participation
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma (GMMG-HD9/DSMM XVIII-trial)
Where
Aachen, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz, Cottbus, Darmstadt, Dessau-Rosslau, Dortmund, Dresden, Duesseldorf, Duisburg, Eschweiler, Essen, Flensburg, Frankfurt, Frankfurt Am Main, Freiburg im Breisgau, Greifswald, Hagen, Halle (Saale), Hamburg, Hannover, Heidelberg, Heilbronn, Homburg, Jena, Kaiserslautern, Karlsruhe, Kempten (Allgau), Kiel, Koblenz, Lebach, Leipzig, Ludwigshafen Am Rhein, Luebeck, Magdeburg, Mainz, Mannheim, Marburg, Meschede, Moenchengladbach, Munich, Mutlangen, Oldenburg, Osnabrueck, Paderborn, Regensburg, Schwaebisch Hall, Siegburg, Speyer, Stuttgart, Tuebingen, Ulm, Villingen-Schwenningen, Wuerzburg
Age
18 years and over
People
451 worldwide
Run by
Universitaetsklinikum Heidelberg AöR
See details and how to join2023-507402-13-00EU 2023-507402-13-00Registry updated 2025-07-09
No phaseRecruitingResearch participation
Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project
Where
Berlin, Garmisch-Partenkirchen
Age
18 years and over
People
120 worldwide
Run by
Medical University Innsbruck
See details and how to joinNCT06821880Registry updated 2025-02-12
Phase 2/3RecruitingTrial-stage medicine
Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma Patients
Where
Aachen, Aschaffenburg, Berlin, Bielefeld, Dachau, Deggendorf, Dortmund, Essen, Frankfurt Am Main, Greifswald, Hamburg, Herne, Jena, Kassel, Lübeck, Muenster, Munich, Nuremberg, Oldenburg, Paderborn, Siegen, Traunstein, Wuerzburg
Age
18 years to 70 years
People
100
Run by
University Hopsital Schleswig Holstein Campus Lübeck
See details and how to joinNCT05665140EU 2022-500453-16-00Registry updated 2024-12-11

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error